Arcadia Biosciences (RKDA) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Arcadia Biosciences (RKDA) is Moderate Underperform.

The composite score behind that read is -0.27, weighing +0.10 of bullish evidence against -0.42 bearish.

Arcadia Biosciences last closed at $0.26, -3.70% on the session.

Against the IVW growth benchmark the position is -4.50% over the forecast window.

The read is built from 15 underlying insights — 1 bullish and 14 bearish.

Agreement across those insights is 93%.

20 graded predictions for RKDA so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Arcadia Biosciences in the 3rd percentile on return on equity, where 100 is best.

Arcadia Biosciences is classified under Consumer Staples / Food Products, with a market capitalisation of $659,100.

StockMap tracks Arcadia Biosciences as the 65th largest of the 66 companies it covers in the Food Products industry, part of the Consumer Staples sector.

Across that group the current two-week reads are 44 Neutral, 21 Moderate Underperform and 1 Moderate Outperform.

On that composite Arcadia Biosciences ranks 58th of 66 in the group, against a group median of -0.13.